These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22353795)

  • 1. Cancer immunoediting in malignant glioma.
    Dunn GP; Fecci PE; Curry WT
    Neurosurgery; 2012 Aug; 71(2):201-22; discussion 222-3. PubMed ID: 22353795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic concepts in glioma immunology.
    Parney IF
    Adv Exp Med Biol; 2012; 746():42-52. PubMed ID: 22639158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The innate immune response in the central nervous system and its role in glioma immune surveillance.
    Friese MA; Steinle A; Weller M
    Onkologie; 2004 Oct; 27(5):487-91. PubMed ID: 15585981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cell-based immunotherapy for malignant gliomas.
    Akasaki Y; Black KL; Yu JS
    Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing the immune system against human glioma.
    Dhodapkar KM; Banerjee D; Steinman RM
    Ann N Y Acad Sci; 2005 Dec; 1062():13-21. PubMed ID: 16461784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunobiology of malignant gliomas.
    Nano R; Ceroni M
    Funct Neurol; 2005; 20(1):39-42. PubMed ID: 15948568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological aspects of experimental brain tumors (review).
    Stavrou D; Bilzer T; Hultén M; Zänker KS; Anzil AP; Haglid KG; Dahme E
    Anticancer Res; 1982; 2(3):151-5. PubMed ID: 6751209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor immune response: what are the roles for gliomas?].
    Dietrich PY
    Rev Neurol (Paris); 2001 Nov; 157(11 Pt 1):1339-48. PubMed ID: 11924003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell- and peptide-based immunotherapeutic approaches for glioma.
    Yamanaka R
    Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of tumor specific immunological response in the patients with malignant brain tumors by the mixed lymphocyte-tumor cell reaction].
    Yoshida S; Takai N; Ono K; Saito T; Tanaka R
    No To Shinkei; 1988 Nov; 40(11):1067-73. PubMed ID: 2975495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of local immunoresistance in glioma.
    Albesiano E; Han JE; Lim M
    Neurosurg Clin N Am; 2010 Jan; 21(1):17-29. PubMed ID: 19944963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
    Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
    Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity.
    Smyth MJ; Dunn GP; Schreiber RD
    Adv Immunol; 2006; 90():1-50. PubMed ID: 16730260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-mediated dormancy: an equilibrium with cancer.
    Teng MW; Swann JB; Koebel CM; Schreiber RD; Smyth MJ
    J Leukoc Biol; 2008 Oct; 84(4):988-93. PubMed ID: 18515327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive immunity maintains occult cancer in an equilibrium state.
    Koebel CM; Vermi W; Swann JB; Zerafa N; Rodig SJ; Old LJ; Smyth MJ; Schreiber RD
    Nature; 2007 Dec; 450(7171):903-7. PubMed ID: 18026089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological Evasion in Glioblastoma.
    Magaña-Maldonado R; Chávez-Cortez EG; Olascoaga-Arellano NK; López-Mejía M; Maldonado-Leal FM; Sotelo J; Pineda B
    Biomed Res Int; 2016; 2016():7487313. PubMed ID: 27294132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune cells as anti-cancer therapeutic targets and tools.
    Johansson M; Tan T; de Visser KE; Coussens LM
    J Cell Biochem; 2007 Jul; 101(4):918-26. PubMed ID: 17265430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunobiology of cancer immunosurveillance and immunoediting.
    Dunn GP; Old LJ; Schreiber RD
    Immunity; 2004 Aug; 21(2):137-48. PubMed ID: 15308095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
    Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of regulatory T cells in malignant glioma.
    Sonabend AM; Rolle CE; Lesniak MS
    Anticancer Res; 2008; 28(2B):1143-50. PubMed ID: 18505050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.